Invest Europe

Response to the European Commission Call for Evidence on the European Biotech Act

Positions & consultation responses

06 Jun 2025

Invest Europe’s response highlights the need to close Europe’s biotech commercialization gap by accelerating time to market for breakthrough innovations, bridging the biotech investment gap, unlocking the potential of data, AI and quantum computing, and strengthening Europe’s entrepreneurial workforce.

Th Kpi C Public Support